These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3683172)

  • 21. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
    Engan T; Krane J; Klepp O; Kvinnsland S
    N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors.
    Eskelinen S; Hiltunen Y; Jokisaari J; Virtanen S; Kiviniitty K
    Magn Reson Med; 1989 Jan; 9(1):35-8. PubMed ID: 2540395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modification of the relative plasma concentrations of methyl and methylene groups in cancer: a study using proton NMR spectroscopy].
    Vion-Dury J; Sciaky M; Confort-Gouny S; Kriat M; Favre R; Grisoli F; Harlé JR; Fontanarava E; Mongin M; Carcassonne Y
    C R Acad Sci III; 1989; 309(10):415-8. PubMed ID: 2514967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NMR blood test for cancer: current status.
    Fossel ET
    Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting 1H NMR spectra of blood plasma: cancer, diet and freezing.
    Bell JD; Brown JC; Norman RE; Sadler PJ; Newell DR
    NMR Biomed; 1988 Apr; 1(2):90-4. PubMed ID: 2484277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease.
    Ono S; Moriyasu F; Nabeshima M; Kajimura K; Yamashita Y; Kimura T; Someda H; Hamato N; Okuma M; Ozawa K
    Cancer; 1992 Sep; 70(6):1638-46. PubMed ID: 1325278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of 1H nuclear magnetic resonance spectroscopy of blood plasma to detect malignancy.
    Okunieff P; Greenberg MD; Zietman A; Kahn J; Westgate S; Neuringer LJ
    J Clin Oncol; 1990 May; 8(5):906-10. PubMed ID: 2332773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.
    Mims MP; Morrisett JD; Mattioli CA; Gotto AM
    N Engl J Med; 1989 Jun; 320(22):1452-7. PubMed ID: 2716796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer.
    Holmes KT; Mackinnon WB; May GL; Wright LC; Dyne M; Tattersall MH; Mountford CE; Sullivan D
    NMR Biomed; 1988 Feb; 1(1):44-9. PubMed ID: 3275022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of malignant tumours by multivariate analysis of proton magnetic resonance spectra of serum.
    Sletten E; Kvalheim OM; Kruse S; Farstad M; Søreide O
    Eur J Cancer; 1990; 26(5):615-8. PubMed ID: 2144752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?
    Leray G; de Certaines JD
    Anticancer Res; 1994; 14(5A):1839-51. PubMed ID: 7847817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [1H-NMR studies of plasma from patients with liver diseases].
    Ono S; Moriyasu F; Tamada T; Kawasaki T; Yamashita Y; Kimura T; Kajimura K; Someda H; Hamato N; Okuma M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Dec; 87(12):2623-8. PubMed ID: 2077159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An NMR blood test for cancer: a critical assessment.
    Chmurny GN; Hilton BD; Halverson D; McGregor GN; Klose J; Issaq HJ; Muschik GM; Urba WJ; Mellini ML; Costello R
    NMR Biomed; 1988 Jun; 1(3):136-50. PubMed ID: 3079310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.
    Engan T; Krane J; Kvinnsland S
    NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1H NMR of plasma for detecting cancer. The effect of trauma on linewidths.
    Sutherland G; Peeling J
    NMR Biomed; 1989 Jul; 2(2):66-9. PubMed ID: 2641293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of human serum lipoproteins: nuclear magnetic resonance supports a micellar model.
    Steim JM; Edner OJ; Bargoot FG
    Science; 1968 Nov; 162(3856):909-11. PubMed ID: 5684497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins.
    Bell JD; Sadler PJ; Macleod AF; Turner PR; La Ville A
    FEBS Lett; 1987 Jul; 219(1):239-43. PubMed ID: 3595877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance spectroscopy in cancer research.
    Smith IC; Princz EJ; Saunders JK
    Can Assoc Radiol J; 1990 Feb; 41(1):32-8. PubMed ID: 2178730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy.
    Otvos JD; Jeyarajah EJ; Bennett DW
    Clin Chem; 1991 Mar; 37(3):377-86. PubMed ID: 2004444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.